iDose® TR Glaucoma Treatment in Albuquerque, NM
What Is iDose® TR for Glaucoma?
The Glaukos iDose TR is a microscopic, medical-grade titanium implant—roughly the size of a single grain of rice—that is gently placed directly inside the eye. Once in place, it works completely behind the scenes to continuously release a precise, therapeutic dose of a prostaglandin analog medication (travoprost) right where it is needed most.
How the Procedure Works
The implantation of iDose TR is a brief, minimally invasive outpatient procedure performed right here at our practice:- Comfort First: The eye is thoroughly numbed with advanced anesthetic drops so you will feel no pain.
- Microscopic Precision: Under a high-powered surgical microscope, Dr. Gillette utilizes a specialized, sterile inserter to guide the device through a tiny corneal incision.
- Secure Anchor: The device is safely anchored within the eye's natural drainage system (the iridocorneal angle), entirely out of your line of sight.
- Fast Recovery: The outpatient process is completed in just a few minutes, allowing you to return home the very same day. It can be performed as a standalone therapy or paired seamlessly during cataract surgery.
Key Patient Benefits
- Freedom From Daily Drops: Significantly reduces or completely eliminates the daily hassle, stinging, and memory fatigue of prescription eye drops.
- 24/7 Consistent Care: Releases medication evenly day and night, eliminating the dramatic "peaks and valleys" in eye pressure associated with missing a drop.
- Reduces Surface Irritation: Because the medication targets the inside of the eye directly, it helps avoid the chronic dry eye and redness frequently caused by topical drop preservatives.
- Biocompatible & Invisible: Made from trusted, medical-grade titanium and an advanced membrane, it rests safely in the eye without being felt or seen by the naked eye.
Who is a Candidate for iDose® TR?
You may be an excellent candidate for this advanced procedure if you:
- Have been diagnosed with open-angle glaucoma (OAG) or ocular hypertension (OHT).
- Currently use prescription glaucoma drops but experience severe dry eye, forget doses, or struggle with drop placement.
- Are planning to undergo cataract surgery and want to manage your glaucoma simultaneously.
Proven Clinical Results
Patients choosing iDose TR can expect powerful, enduring pressure control backed by exhaustive clinical trials published by Ophthalmology Times and Glaukos Clinical Data:
- 81% Drop Freedom: In pivotal FDA trials, 81% of patients were completely free of topical, eye-pressure-lowering drops at the 12-month mark.
- Years of Control: Clinical data shows that the majority of patients maintained optimal eye pressure control up to 3 years after a single administration.
- Excellent Safety History: The device demonstrated no clinically significant loss of corneal endothelial cells and zero serious corneal adverse events.
Important Safety Information & Contraindications
To ensure patient safety, iDose TR is contraindicated and cannot be utilized if you have any of the following conditions:- Active or suspected ocular or periocular infections.
- Corneal endothelial cell dystrophy (such as Fuchs' Dystrophy or corneal guttatae).
- A history of prior corneal transplantation or endothelial cell transplants (such as DSAEK).
- A known hypersensitivity or allergy to travoprost or any components of the device.
- Narrow iridocorneal angles (Shaffer grade < 3) or angle abnormalities.
Take the Next Step for Your Vision
Our Location
7110 Wyoming Blvd NE
Albuquerque, NM 87109
